Aethlon Medical, Inc.
AEMD
$1.76
-$0.21-10.66%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | 574.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | 574.20K |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | 574.20K |
| SG&A Expenses | 9.83M | 10.71M | 10.99M | 11.77M | 12.33M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.83M | 10.71M | 10.99M | 11.77M | 12.33M |
| Operating Income | -9.83M | -10.71M | -10.99M | -11.77M | -11.76M |
| Income Before Tax | -9.56M | -11.27M | -11.50M | -12.21M | -12.25M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.56 | -11.27 | -11.50 | -12.21 | -12.25 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.56M | -11.27M | -11.50M | -12.21M | -12.25M |
| EBIT | -9.83M | -10.71M | -10.99M | -11.77M | -11.76M |
| EBITDA | -9.49M | -10.36M | -10.63M | -11.42M | -11.40M |
| EPS Basic | -12.78 | -22.80 | -30.96 | -39.00 | -40.20 |
| Normalized Basic EPS | -8.01 | -12.53 | -17.64 | -22.66 | -23.39 |
| EPS Diluted | -12.78 | -22.80 | -30.96 | -39.00 | -40.20 |
| Normalized Diluted EPS | -8.01 | -12.53 | -17.64 | -22.66 | -23.39 |
| Average Basic Shares Outstanding | 4.75M | 3.32M | 1.88M | 1.26M | 1.22M |
| Average Diluted Shares Outstanding | 4.75M | 3.32M | 1.88M | 1.26M | 1.22M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |